Summary
A 24-year-old software engineer was denied a security clearance under Guideline H (Drug Involvement) due to a history of illegal drug use, specifically marijuana and psilocybin mushrooms. Disqualifying conditions cited included AG ¶ 25(a), AG ¶ 25(c), and AG ¶ 25(g).
The applicant admitted to using psilocybin mushrooms shortly after receiving an interim security clearance. His drug use continued until less than 16 months before the hearing, raising concerns about his reliability and trustworthiness. This recent lapse was seen as demonstrating a lack of appreciation for the responsibilities associated with holding a security clearance.
While the applicant showed significant personal and professional growth since his last drug use in November 2009, and mitigating conditions AG ¶ 26(b)(2) and AG ¶ 26(b)(4) were considered, the judge determined there was insufficient evidence to overcome the security concerns. Consequently, the security clearance was denied.
Why the Applicant Was Denied
- The applicant admitted to using illegal drugs, including psilocybin mushrooms, shortly after being granted an interim security clearance.
- The applicant's drug use continued until less than 16 months prior to the hearing, raising concerns about his reliability and trustworthiness.
- The applicant's recent lapse in drug use demonstrated a lack of appreciation for the expectations of holding a security clearance.
Conditions Referenced
- AG ¶ 25(a)raisedAny Drug Abuse
- AG ¶ 25(c)raisedIllegal Drug Possession
- AG ¶ 25(g)raisedAny Illegal Drug Use After Being Granted a Security Clearance
- AG ¶ 26(b)(2)appliedChanging or Avoiding the Environment Where Drugs Were Used
- AG ¶ 26(b)(4)appliedA Signed Statement of Intent with Automatic Revocation of Clearance for Any Violation
Key Rule Quoted
“Any doubt concerning personnel being considered for access to classified information will be resolved in favor of national security.”
Procedural Posture
- SOR issuedSep 17, 2010
- Answer filedOct 4, 2010
- Hearing heldFeb 15, 2011
- Decision dateMar 7, 2011
Cite For
- Evaluation of Drug Involvement Under Guideline H
- Consideration of Mitigating Conditions Related to Drug Use
- Importance of Demonstrating a Sustained Period of Abstinence From Drug Use